Pavel Pevzner, chair professor of computer science, University of California, San Diego
Felix Grant opens his eyes to the world of visualisation
Felix Grant on how statistical computing is charting the evolution of the brain and skull
Choices of data acquisition software are clouded by a bewildering array of data formats. For successful integration from instrument to analysis package, the simplest option is often the best, discovers Sian Harris.
Clare Samson discovers how ELNs are finding a home in bioinformatics applications
David Robson on how molecular modelling is making headway in the laborious process of drug discovery.
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
